Table of Contents
List of Tables
List of Figures
1 Introduction
1.1 What Is This Report About?
1.2 Interventional Cardiology Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Interventional Cardiology Market, North America
2.1 Interventional Cardiology Market, North America, Revenue ($m), 2024-2036
2.2 Interventional Cardiology Market, North America, Revenue ($m), 2024-2036
2.3 Interventional Cardiology Market, North America, Volume (Units), 2024-2036
2.4 Interventional Cardiology Market, North America, Volume (Units), 2024-2036
2.5 Interventional Cardiology Market, North America, Company Share by Revenue ($m), 2025
3 Interventional Cardiology Market, Canada
3.1 Interventional Cardiology Market, Canada, Revenue ($m), 2024-2036
3.1.1 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.3 PTCA Balloon Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.4 Structural Heart Occlusion Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.5 Transcatheter Accessories Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Interventional Cardiology Market, Canada, Volume (Units), 2024-2036
3.2.1 Coronary Stents Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.3 PTCA Balloon Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.4 Structural Heart Occlusion Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.5 Transcatheter Accessories Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Interventional Cardiology Market, Canada, Average Price ($), 2024-2036
3.4 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2025
4 Interventional Cardiology Market, Mexico
4.1 Interventional Cardiology Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Coronary Stents Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.3 PTCA Balloon Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.4 Structural Heart Occlusion Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.5 Transcatheter Accessories Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Interventional Cardiology Market, Mexico, Volume (Units), 2024-2036
4.2.1 Coronary Stents Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.3 PTCA Balloon Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.4 Structural Heart Occlusion Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.5 Transcatheter Accessories Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Interventional Cardiology Market, Mexico, Average Price ($), 2024-2036
4.4 Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), 2025
5 Interventional Cardiology Market, United States
5.1 Interventional Cardiology Market, United States, Revenue ($m), 2024-2036
5.1.1 Coronary Stents Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.3 PTCA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.4 Structural Heart Occlusion Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.5 Transcatheter Accessories Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Interventional Cardiology Market, United States, Volume (Units), 2024-2036
5.2.1 Coronary Stents Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2024-2036
5.2.3 PTCA Balloon Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.4 Structural Heart Occlusion Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.5 Transcatheter Accessories Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Interventional Cardiology Market, United States, Average Price ($), 2024-2036
5.4 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2025
6 Interventional Cardiology Market Pipeline Products
6.1 Interventional Cardiology Market Pipeline Products
6.2 Interventional Cardiology – Pipeline Products by Stage of Development
6.3 Interventional Cardiology – Pipeline Products by Segment
6.4 Interventional Cardiology – Pipeline Products by Territory
6.5 Interventional Cardiology – Pipeline Products by Regulatory Path
6.6 Interventional Cardiology – Pipeline Products by Estimated Approval Date
7 Overview of Key Companies in North America Interventional Cardiology Market
7.1 Boston Scientific Corp
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Koninklijke Philips NV
7.3.1 Company Overview
7.4 Medtronic Plc
7.4.1 Company Overview
7.5 Shockwave Medical Inc
7.5.1 Company Overview
7.6 Terumo Corp
7.6.1 Company Overview
7.7 Asahi Intecc Co Ltd
7.7.1 Company Overview
7.8 Teleflex Inc
7.8.1 Company Overview
7.9 W. L. Gore & Associates Inc
7.9.1 Company Overview
7.10 AtriCure Inc
7.10.1 Company Overview
8 Recent Developments
8.1 Corporate Communications
8.1.1 Mar 10, 2026: Butterfly Network Appoints David Horsley as Senior Vice President of Innovation, Butterfly Embedded
8.1.2 Feb 19, 2026: Elumn8 Medical secures Series C funding and unveils rebrand
8.1.3 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.1.4 Nov 26, 2025: Orchestra BioMed Grants Inducement Stock Options Under Nasdaq Listing Rule 5635(c)(4)
8.1.5 Nov 21, 2025: Butterfly Network to Participate in 8th Annual Evercore Healthcare Conference
8.1.6 Nov 19, 2025: Okami Medical Secures $45 Million Financing and Appoints New CEO
8.1.7 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.1.8 Nov 13, 2025: Efferent Labs Appoints Philip Manos as Chief Science Officer
8.1.9 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.1.10 Nov 10, 2025: TEDCO Announces Recent Company Formation and Technology Assessment Awardees
8.1.11 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.1.12 Nov 04, 2025: Esperion Appoints John Harlow as Chief Commercial Officer
8.1.13 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.1.14 Nov 03, 2025: Prolocor Publishes Study in Journal of Invasive Cardiology
8.1.15 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.16 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.17 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.18 Oct 29, 2025: Butterfly Network Participates at UBS Global Healthcare Conference 2025
8.1.19 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.20 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
8.1.21 Oct 28, 2025: Southwestern Vermont Medical Center Appoints Estevan Garcia, MD, As President And CEO
8.1.22 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.23 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing
8.1.24 Oct 27, 2025: Butterfly Network Strengthens Global Information Security Posture With ISO 27001, SOC-2 Type 2, C5 Germany, and NHS DSPT Accreditations
8.1.25 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
8.1.26 Oct 24, 2025: Payman Khales Becomes Integer President and CEO
8.1.27 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.1.28 Oct 09, 2025: Butterfly Network Names John Doherty Chief Financial Officer
8.1.29 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.30 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts
8.1.31 Sep 12, 2025: Cedars-Sinai Receives $26M to Research Heart Valve Disease
8.1.32 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.33 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
8.2.2 Mar 12, 2026: Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
8.2.3 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance
8.2.4 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.2.5 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.6 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.2.7 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.2.8 Oct 17, 2025: Butterfly Network To Report Third Quarter Financial Results
8.2.9 Oct 08, 2025: AtriCure To Announce Third Quarter Financial Results
8.2.10 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
8.2.11 Oct 02, 2025: AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results
8.2.12 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.2.13 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.14 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.15 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.16 May 12, 2025: Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
8.3 Government and Public Interest
8.3.1 Mar 03, 2026: Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
8.3.2 Feb 23, 2026: AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
8.3.3 Feb 17, 2026: Butterfly Network to Participate at TD Cowen 46th Annual Health Care Conference on March 3, 2026
8.3.4 Dec 22, 2025: AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
8.3.5 Nov 21, 2025: Butterfly Network to Participate in 8th Annual Evercore Healthcare Conference
8.3.6 Nov 18, 2025: AtriCure to Participate in Piper Sandler 37th Annual Healthcare Conference
8.3.7 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.8 Oct 29, 2025: Butterfly Network Participates at UBS Global Healthcare Conference 2025
8.3.9 Oct 27, 2025: AtriCure to Participate in Upcoming Investor Conferences
8.3.10 Oct 27, 2025: AngioDynamics to Participate in the UBS Global Healthcare Conference
8.3.11 Oct 14, 2025: AGFA HealthCare Powers Enterprise Imaging Modernization Across North America
8.3.12 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
8.3.13 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.3.14 Aug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
8.3.15 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
8.3.16 Jul 30, 2025: Artivion to Participate in Upcoming Investor Conferences
8.3.17 Jul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
8.3.18 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
8.3.19 May 22, 2025: Butterfly Network to Participate at William Blair 45th Annual Growth Stock Conference
8.3.20 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.21 Apr 24, 2025: Mabwell To Present Clinical Data of 9mw2821 Combined With Toripalimab in Patients With UC in an Oral Presentation at 2025 ASCO
8.4 Legal And Regulatory
8.4.1 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
8.4.2 Aug 28, 2025: CNC Technologies Receives 510(K) Clearance For Duoblade Prime
8.5 Other Significant Developments
8.5.1 Mar 17, 2026: State of Florida and Cordis Announce Planned Investment
8.5.2 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.5.3 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.5.4 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.5 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.5.6 Nov 03, 2025: News Updates for Q3 2025
8.5.7 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.8 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
8.5.9 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.5.10 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
8.5.11 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
8.5.12 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
8.5.13 Oct 10, 2025: Royal Columbian Hospital Redevelopment October Project Update
8.5.14 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.5.15 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)
8.5.16 Oct 05, 2025: UAB Medicine Successfully Implants Two TransForm McCarthy Mitral Annuloplasty Rings
8.5.17 Sep 30, 2025: Novarad Installs NovaCardio with EncaptureMD Structured Reporting at Capitol Medical Center
8.5.18 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program
8.5.19 Sep 25, 2025: ConcertAI’s Terarecon Surpasses 2,000 Global Customers, Accelerating Cloud-First SAAS Transformation to Further Unlock Productivity for Healthcare Providers
8.5.20 Sep 22, 2025: Emergent BioSolutions Secures $29 Million in Product Orders from International Government Partner
8.5.21 Sep 12, 2025: Cedars-Sinai Receives $26M to Research Heart Valve Disease
8.5.22 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death
8.5.23 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry
8.5.24 Aug 13, 2025: Positron Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
8.6 Product News
8.6.1 Mar 03, 2026: Orchestra Biomed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
8.6.2 Feb 22, 2026: Contamac Obtains PMA Approval for Optimum Infinite
8.6.3 Feb 22, 2026: Wondfo USA Receives CLIA Approval for HORMONElife Early Result Pregnancy Test Strip
8.6.4 Feb 19, 2026: Elumn8 Medical secures Series C funding and unveils rebrand
8.6.5 Feb 02, 2026: Artivion Announces Presentation of Positive New Clinical Data From NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
8.6.6 Jan 28, 2026: Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities at MD&M West 2026
8.6.7 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
8.6.8 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.6.9 Nov 25, 2025: CRISPR Phase 1 Trial Suggests First-of-Its-Kind Heart Treatment
8.6.10 Nov 21, 2025: Imperative Care Reports Real-World ADAPT
2.0 Data in Ischemic Stroke Patients Using Zoom Stroke System
8.6.11 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results
8.6.12 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.6.13 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.6.14 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.6.15 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
8.6.16 Nov 13, 2025: EnVVeno Faces FDA Rejection on VenoValve Application
8.6.17 Nov 12, 2025: VitAA Medical Receives FDA Clearance for AiORTA Plan in Aortic Care
8.6.18 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.6.19 Nov 11, 2025: Sentante Introduces Innovative Remote Robotic Stroke Procedure
8.6.20 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction
8.6.21 Nov 06, 2025: Artivion Treats First Patient in ARTIZEN Trial for Arcevo LSA
8.6.22 Nov 06, 2025: TRiCares Completes First TC-L 55mm Topaz Implant in Ongoing TRICURE EU Pivotal Study
8.6.23 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.6.24 Nov 05, 2025: Fluid Control Solutions For MedTech
8.6.25 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.6.26 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study
8.6.27 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.6.28 Nov 03, 2025: Prolocor Publishes Study in Journal of Invasive Cardiology
8.6.29 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
8.6.30 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.6.31 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
8.6.32 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.6.33 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.6.34 Oct 29, 2025: Penumbra Study Supports Lightning Flash
2.0 Mechanical Thrombectomy System
8.6.35 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing
8.6.36 Oct 27, 2025: Dr. Sorajja's Tendyne Device Revolutionizes Heart Valve Replacement
8.6.37 Oct 26, 2025: Real-World Data Presented at TCT 2025 Shows EggNest Complete Radiation Protection System Reduces Radiation Exposure for Cath Lab Team
8.6.38 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
8.6.39 Oct 24, 2025: Protaryx Medical Submits 510(k) Application for Next-Generation Transseptal Puncture Device
8.6.40 Oct 24, 2025: Terumo Interventional Systems Announces FDA Clearance for OPUSWAVE Dual Sensor Imaging System and DualView Imaging Catheter
8.6.41 Oct 24, 2025: Yorlabs Receives FDA 510(k) Clearance for Zero-CapEx Intracardiac Imaging System
8.6.42 Oct 23, 2025: Ancora Heart Inc. Reports Two-Year Results on AccuCinch System in Heart Failure Patients
8.6.43 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.6.44 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
8.6.45 Oct 22, 2025: Norav Medical Launches TeleEVENT – Full Disclosure Event Recorder for Remote Cardiac Telemetry
8.6.46 Oct 21, 2025: SpectraWAVE Receives 510(k) Clearance for X1-FFR, an AI-Enabled, Wire-Free, Drug-Free Physiology Solution
8.6.47 Oct 15, 2025: Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System
8.6.48 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
8.6.49 Oct 13, 2025: Getinge’s Advanta V12 Receives CE Mark for Major Bridging Indications
8.6.50 Oct 09, 2025: BD Enrolls First Patient in XTRACT Registry for Rotarex Catheter System
8.6.51 Oct 09, 2025: Asahi Kasei Achieves FDA Approval for ZOLL’s Zenix Monitor/Defibrillator
8.6.52 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.6.53 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.6.54 Oct 07, 2025: John Muir Health Cardiologists Provide Innovative Repair for Leaky Heart Valves
8.6.55 Oct 06, 2025: FDA Approves Pivotal Trial For AorticLab’s FLOWer Embolic Protection System
8.6.56 Oct 05, 2025: UAB Medicine Successfully Implants Two TransForm McCarthy Mitral Annuloplasty Rings
8.6.57 Oct 01, 2025: Adagio Medical Completes Enrollment in FULCRUM-VT Clinical Trial for Ventricular Tachycardia
8.6.58 Sep 30, 2025: Novarad Installs NovaCardio with EncaptureMD Structured Reporting at Capitol Medical Center
8.6.59 Sep 30, 2025: Relief Cardiovascular Announces First-In-Human Procedures With Transcatheter Smart Implant for Heart Failure Treatment
8.6.60 Sep 29, 2025: Spur® Elute DEEPER Coronary Study Completes Enrollment
8.6.61 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month
8.6.62 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death
8.6.63 Sep 11, 2025: First Patient Enrolled in Dubstent Diabetes Trial: Targeting Improved PCI Outcomes
8.6.64 Sep 10, 2025: JenaValve Announces ESC Guidelines Recognize TAVI for Aortic Regurgitation
8.6.65 Sep 08, 2025: Shape Memory Medical Completes Enrollment in EMBO-PMS Registry
8.6.66 Sep 03, 2025: Laza Medical Completes First Human Use of Real-Time AI Heart Model for Cardiac Procedures
8.6.67 Jun 30, 2025: InterShunt Enrolls First Patient in New Heart Failure Study
8.6.68 May 31, 2025: Daiichi Sankyo : ENHERTU Reduced the Risk of Death by 30% Versus Ramucirumab Plus Paclitaxel in Patients with Gastric Cancer in Phase 3 Trial
8.7 Strategy And Business Planning
8.7.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
8.7.2 Nov 11, 2025: Expanse Medical Expands to Providence, Rhode Island
8.7.3 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.7.4 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.7.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.7.6 Oct 27, 2025: Remedy Robotics And Mission Thrombectomy Partner To Expand Access To Thrombectomy For Stroke
8.7.7 Oct 27, 2025: Cardiovascular Research Foundation Partners With Fogarty Innovation
8.7.8 Sep 22, 2025: Emergent BioSolutions Secures $29 Million in Product Orders from International Government Partner
8.7.9 Sep 11, 2025: Penumbra, Inc. Establishes Manufacturing Plant in Costa Rica
8.7.10 Sep 03, 2025: Laza Medical Completes First Human Use of Real-Time AI Heart Model for Cardiac Procedures
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 GlobalData Consulting
9.3 Contact Us
9.4 Disclaimer
